Brief: Actinium To Present At 2019 Society Of Nuclear Medicine And Molecular Imaging Annual Meeting
20/06/2019 13:26
June 20 (Reuters) - Actinium Pharmaceuticals Inc ATNM.A :
* ACTINIUM'S PORTFOLIO OF ANTIBODY RADIATION-CONJUGATES TO
BE
HIGHLIGHTED IN TWO ORAL AND TWO POSTER PRESENTATIONS AT THE 2019
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING
Source text for Eikon: ID:nPn4r2WCLa
Further company coverage: ATNM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actinium Pharmaceuticals
See all newsBrief: Actinium Pharmaceuticals - Receives Two Canadian Patent Allowances For Actimab-A And Iomab-Act Programs
Brief: ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCS
Brief: Actinium Pharmaceuticals Says ATNM-400 Shows Superior Efficacy To Xtandi In Prostate Cancer
Brief: Actinium Pharmaceuticals Announces ATNM-400 A Novel Non-PSMA Targeting First In Class Prostate Cancer Radiotherapy Leveraging Actinium-225
Brief: Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities